Physician profile
Wendy U Bui
NPI 1770770893
$3,947.58
in general payments reported to CMS, 2019-2025
19 companies · $588 in 2025
The $588 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $74.70 · 2021: $571 · 2022: $976 · 2023: $528 · 2024: $815 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,869 · Education: $61.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,868.93 |
| Education | $61.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $677.42 | 2019-2023 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $401.40 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $361.88 | 2019-2025 | Cequa |
| Oyster Point Pharma, INC. | $355.25 | 2022-2025 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $345.89 | 2022-2025 | Miebo, Infuse, Xiidra |
| Alcon Vision LLC | $309.71 | 2019-2025 | Precision7, Tryptyr, Rocklatan |
| Kala Pharmaceuticals, INC. | $303.19 | 2021-2022 | |
| Harrow Eye, LLC | $254.94 | 2024-2025 | Vevye |
| Novartis Pharmaceuticals Corporation | $210.54 | 2019-2023 | |
| Glaukos Corporation | $151.60 | 2024 | Radius |
| Coopervision INC. | $150.17 | 2024-2025 | Paragon Crt, Myday Contact Lens, Misight Contact Lens |
| Tarsus Pharmaceuticals, INC. | $119.47 | 2024-2025 | Xdemvy |
| Allergan, INC. | $97.01 | 2022 | |
| Dompe US, INC. | $54.67 | 2024-2025 | Oxervate |
| Abbvie INC. | $44.90 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $43.64 | 2022 | |
| Abb Con-Cise Optical Group LLC | $28.49 | 2019 | |
| Plexus Optix, INC. | $20.38 | 2021 | |
| Eyevance Pharmaceuticals LLC | $17.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Bui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.